Vergoeding 2017-2021 voor ATC-subgroep N05A : Antipsychotica
- Raming voor de totale Zvw-populatie
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
N05AA Fenothiazinen met alifatische zijketen | 13.146 | 8.532 | 8.500 | 7.325 | 3.648 |
N05AB Fenothiazinen met piperazinestructuur | 261.370 | 314.650 | 598.460 | 627.600 | 641.670 |
N05AC Fenothiazinen met piperidinestructuur | 22.539 | 20.056 | 18.799 | 17.160 | 15.665 |
N05AD Butyrofenonderivaten | 1.516.800 | 1.350.300 | 1.356.900 | 1.412.100 | 1.395.700 |
N05AE Indoolderivaten | 336.620 | 459.290 | 555.900 | 545.730 | 534.940 |
N05AF Thioxantheenderivaten | 1.236.300 | 1.165.900 | 1.089.800 | 1.080.300 | 1.007.100 |
N05AG Difenylbutylpiperidinederivaten | 761.320 | 741.910 | 1.058.100 | 1.019.800 | 987.210 |
N05AH Diazepinen oxazepinen thiazepinen en oxepinen | 11.512.700 | 13.310.900 | 15.606.900 | 16.411.400 | 16.547.800 |
N05AL Benzamiden | 530.440 | 505.800 | 642.240 | 738.200 | 1.619.600 |
N05AN Lithiumzouten | 1.010.300 | 1.123.300 | 1.623.700 | 3.574.800 | 4.926.600 |
N05AX Overige antipsychotica | 25.675.600 | 25.655.000 | 27.765.100 | 29.322.600 | 28.669.100 |
Totaal | 42.877.135 | 44.655.638 | 50.324.399 | 54.757.015 | 56.349.033 |